The Growing Challenges To Drug Cos.' Preemption Defense

In the wake of the U.S. Supreme Court's decisions in Wyeth v. Levine[1] and Merck Sharp & Dohme Corp. v. Albrecht,[2] drug manufacturers face challenges in establishing a preemption defense when...

Already a subscriber? Click here to view full article